Publication | Open Access
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
12
Citations
36
References
2021
Year
No IHC biomarker evaluated showed a significant association with a response or survival outcomes in TNBC patients. Clinical stage, LNR and RCB stood out for strongly influencing survival.
| Year | Citations | |
|---|---|---|
Page 1
Page 1